One plausible hypothesis to explain this phenomenon is that the direct interaction between c-Met-expressing CD8+ T cells and tumor cells fosters a feedback loop, resulting in an upregulation of c-Met expression on the surface of CTLs together with a reduction in inhibitory molecules, subsequently enhancing their activation. The gene discussed is MET; the disease is neoplasm.